|
BICD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.008200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.252400E-01 |
| Normal-vs-Stage2 |
7.047800E-01 |
| Normal-vs-Stage3 |
1.471840E-01 |
| Normal-vs-Stage4 |
3.057800E-01 |
| Stage1-vs-Stage2 |
9.070400E-01 |
| Stage1-vs-Stage3 |
1.286400E-01 |
| Stage1-vs-Stage4 |
2.825800E-01 |
| Stage2-vs-Stage3 |
1.296370E-01 |
| Stage2-vs-Stage4 |
2.730000E-01 |
| Stage3-vs-Stage4 |
9.559400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.494600E-01 |
| Normal-vs-AfricanAmerican |
7.636000E-01 |
| Normal-vs-Asian |
6.423200E-01 |
| Caucasian-vs-AfricanAmerican |
8.972600E-01 |
| Caucasian-vs-Asian |
7.541200E-01 |
| AfricanAmerican-vs-Asian |
7.059000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.481800E-02 |
| Normal-vs-Female |
6.956100E-03 |
| Male-vs-Female |
5.598300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.234400E-01 |
| Normal-vs-Extreme_Weight |
1.760970E-01 |
| Normal-vs-Obese |
1.707770E-01 |
| Normal-vs-Extreme_Obese |
1.062560E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.061180E-01 |
| Normal_Weight-vs-Obese |
5.982200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.644900E-03 |
| Extreme_Weight-vs-Obese |
4.842100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.837600E-02 |
| Obese-vs-Extreme_Obese |
2.637000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.746000E-02 |
| Normal-vs-Age(41-60Yrs) |
3.838200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.464420E-01 |
| Normal-vs-Age(81-100Yrs) |
8.15080000000634E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.163980E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.290200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.743600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.931600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.83789000000045E-05 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.031800E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.693860E-02 |
| Normal-VS-Type2 PRCC |
3.073800E-01 |
| Normal-VS-KIRP CIMP |
1.272420E-02 |
| Normal-VS-Unclassified PRCC |
5.460000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.871000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.422900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.547800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.099720E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.810810E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.481970E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.609900E-02 |
| Normal-vs-N1 |
4.672300E-02 |
| Normal-vs-N2 |
3.079600E-01 |
| N0-vs-N1 |
2.172200E-02 |
| N0-vs-N2 |
2.698800E-01 |
| N1-vs-N2 |
5.722600E-01 |
|
|
